ROCKVILLE, Md.--(BUSINESS WIRE)-- Emergent BioSolutions Inc. (NYSE: EBS) announced today that the company will be webcasting its presentation at the Jefferies 2011 Global Healthcare Conference in London on Tuesday, September 27, 2011 at 3:40 PM BST. During the presentation, a member of the company’s management team will provide a corporate overview, which may include a discussion of the company’s business activities and financial performance.
A webcast of this presentation will be available both live and by replay, accessible from the Emergent website www.emergentbiosolutions.com under “Investors.”
About Emergent BioSolutions Inc.
Emergent BioSolutions protects and enhances life by developing and manufacturing vaccines and therapeutics that are supplied to healthcare providers and purchasers for use in preventing and treating disease. Emergent's marketed and investigational products target infectious diseases, oncology and autoimmune disorders. Additional information about the company may be found at www.emergentbiosolutions.com.
CONTACT:
Emergent BioSolutions Inc.
Investors:
Robert G. Burrows
Vice President, Investor Relations
301-795-1877
[email protected]
or
Media:
Tracey Schmitt
Vice President, Corporate Communications
301-795-1800
[email protected]
KEYWORDS: United Kingdom United States Europe North America Maryland
INDUSTRY KEYWORDS: Health Biotechnology Pharmaceutical Professional Services Finance
MEDIA:
| Logo |